The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,...) develop normally (neurologic and cardiologic examination).
Study contains several study parts (protocol version 4.4): \*\*\*\*\*\*\*\*\*\*Part I. Pregnancy, delivery and maternal health\*\*\*\*\*\*\*\*\*\* Part I.I.A. Registration study 'Cancer during pregnancy' mother and neonate None Part I.I.B. Effects of prenatal exposure to cancer treatment on fetal growth. The association between placental pathophysiologic mechanisms (histopathology and immunohistochemistry), circulating maternal factors and fetal growth. From participating women, a maternal blood sample will be collected during or shortly after birth. Also, an umbilical cord blood sample and placental and umbilical cord biopsies will be drawn. Part I.II. Measurement of maternal and paternal anxiety and emotional needs when confronted with a cancer diagnosis during pregnancy The participants will be asked to complete questionnaires. \*\*\*\*\*\*\*\*\*\*Part II. Child\*\*\*\*\*\*\*\*\*\* Long term follow up of children and adolescents in utero exposed to chemotherapy and/or radiotherapy Regular check-ups of the child, at the age of 6 months, 18 months, 3y, 6y, 9y, 12y, 15y, and 18y, and after the age of 18 years: 5-yearly cardiologic assessment and questionnaires (23y, 28y, 33y, 38y, and 43y). Optional at the ages of 9y, 12y, 15y and 18y: MRI session. Summary part I: Prospectively the outcome of mothers diagnosed and/or treated for cancer during pregnancy will be registered and investigated. Summary Part II: In a prospective trial we invite children that were exposed to cytotoxic drugs or radiotherapy in utero for a standardized neurological and cardiological examination. The examinations will be done by qualified psychologists, neurological and cardiological pediatricians.
Study Type
OBSERVATIONAL
Enrollment
5,000
Follow-up of the mothers diagnosed with cancer during pregnancy
treatment during pregnancy, obstetrical outcome, maternal survival
Time frame: anticipated
Follow-up of the children antenatally exposed to chemotherapy or radiotherapy
neurologic and cardiologic outcome
Time frame: anticipated
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cooper University Hospital (2015-ongoing)
Camden, New Jersey, United States
RECRUITINGInstituto Alexander Fleming
Buenos Aires, Argentina
WITHDRAWNUniversitätsklinik für Frauenheilkunde und Geburtshilfe (retrospective 2016-2018)
Graz, Austria
TERMINATEDUCL Brussels (2013-ongoing)
Brussels, Belgium
RECRUITINGUZ Gasthuisberg, Katholieke Universiteit Leuven (2004-ongoing)
Leuven, Belgium
RECRUITINGUniversity Hospital Ostrava (2018-ongoing)
Ostrava, Czechia
RECRUITING3rd medical faculty of Charles University (2010-ongoing)
Prague, Czechia
RECRUITINGCopenhagen University Hospital (2015-ongoing)
Copenhagen, Denmark
RECRUITINGHopital Bichat-Claude-Bernard (retrospective until 2018)
Paris, France
TERMINATEDUniversitätsklinik Freiburg (retrospective until 2018)
Freiburg im Breisgau, Germany
TERMINATED...and 23 more locations